Scopus BioPharma Inc.
SCPS
$0.0003
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -8.70M | -9.40M | -11.61M | -16.40M | -15.90M |
| Total Depreciation and Amortization | 1.00K | 1.30K | 1.70K | 1.90K | 2.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -606.10K | -519.50K |
| Total Other Non-Cash Items | -329.20K | 0.00 | 246.70K | 1.17M | -231.80K |
| Change in Net Operating Assets | 5.98M | 4.49M | 3.23M | 3.98M | 3.13M |
| Cash from Operations | -3.04M | -4.91M | -8.13M | -11.85M | -13.52M |
| Capital Expenditure | 0.00 | 0.00 | -1.60K | -1.60K | -3.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -1.60K | -1.60K | -3.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -104.50K |
| Issuance of Common Stock | 934.50K | 899.50K | -- | 9.75M | 9.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.28M | 1.36M | 241.90K | -1.27M | -1.27M |
| Cash from Financing | 2.22M | 2.26M | 241.90K | 8.48M | 8.38M |
| Foreign Exchange rate Adjustments | 31.50K | 74.20K | 67.80K | 53.40K | 41.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -794.30K | -2.57M | -7.82M | -3.32M | -5.10M |